There is evidence that certain drugs, particularly biological TNF-alpha inhibitors, which are commonly used in patients with IBD, have been associated with an increase in the risk of venous thromboembolism (VTE) through the promotion of endothelial dysfunction and thrombus formation [11]. This evidence concerns the gene TNF and irritable bowel syndrome.